Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 30 | Tighe BrettChief Financial Officer | OKTAOkta, Inc. Open-market sale · 10b5-1 plan | SELL | $951K 10.0K sh | Jan 15, 2026 |
| 51 | Feinberg PeterDirector |  IMRXImmuneering CorpOpen-market purchase | BUY | $87K 20.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 49 | Hildebrandt John DPresident and COO |  PSMTPRICESMART INCOpen-market sale | SELL | $1.02M 7,421 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 48 | DiGravio Karen AnnTrustee |  GLQClough Global Equity FundOpen-market purchase | BUY | $3,062 378 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 46 | Kovaleski PaulEVP-Chief Merch. Officer | PSMTPRICESMART INC Open-market sale | SELL | $582K 4,255 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 46 | Infante Beatriz VDirector | PSMTPRICESMART INC Open-market sale | SELL | $273K 1,995 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 44 | Brumana RodrigoChief Financial Officer |  JOBYJoby Aviation, Inc.Open-market sale | SELL | $7,756 523 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 43 | Baller LanceDirector, 10% Owner |  GBCSSELECTIS HEALTH, INC.Open-market purchase | BUY | $14K 6,192 sh | Jan 14, 2026 traded Dec 18, 2025 |
| 43 | Duffy Sean P.Director, Chief Executive Officer |  OMDAOmada Health, Inc.Open-market sale | SELL | $2.15M 140.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 43 | Duffy Sean P.Director, Chief Executive Officer | OMDAOmada Health, Inc. Open-market sale | SELL | $1.45M 90.5K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 40 | Billingsley ChesterDirector, Chief Executive Officer, 10% Owner |  MNTRMentor Capital, Inc.Open-market purchase | BUY | $204K 11 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 40 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF |  OLMAOlema Pharmaceuticals, Inc.Open-market sale | SELL | $1.37M 49.8K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 39 | Janks Leon CDirector | PSMTPRICESMART INC Open-market sale | SELL | $207K 1,501 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $63K 176 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $63K 170 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $102K 284 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Bricker JudeDirector, Chief Executive Officer |  SNCYSun Country Airlines Holdings, Inc.Open-market sale | SELL | $89K 5,062 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Frank MalcolmDirector |  FDSFACTSET RESEARCH SYSTEMS INCOpen-market sale | SELL | $452K 1,527 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $81K 226 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $65K 181 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $133K 365 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Janks Leon CDirector | PSMTPRICESMART INC Open-market sale | SELL | $205K 1,499 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $56K 156 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 39 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $148K 405 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 38 | DiGravio Karen AnnTrustee |  GLOClough Global Opportunities FundOpen-market purchase | BUY | $1,274 213 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 38 | Allison EricChief Product Officer | JOBYJoby Aviation, Inc. Open-market sale | SELL | $319K 21.5K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 38 | DiGravio Karen AnnTrustee |  GLVClough Global Dividend & Income FundOpen-market purchase | BUY | $774 124 sh | Jan 14, 2026 traded Jan 14, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $283K 10.0K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 37 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF | OLMAOlema Pharmaceuticals, Inc. Open-market sale | SELL | $1.01M 35.0K sh | Jan 14, 2026 traded Jan 14, 2026 |
| 37 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $34K 200.0K sh | Jan 14, 2026 traded Jan 8, 2026 |
| 37 | Baker Bruce DDirector |  CMTVCOMMUNITY BANCORP /VTOpen-market purchase | BUY | $5,040 180 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $10K 27 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $7,047 19 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | Mangione Christopher MichaelChief Acct. Off. & VP, Finance | SNCYSun Country Airlines Holdings, Inc. Open-market sale | SELL | $4,489 256 sh | Jan 14, 2026 traded Jan 12, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K